Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 15
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Should I stay or should I go? Connecting bird behavior during migration to fat stores and antioxidant capacity

    Thank you to our backers for $5600! We actually need up to $24000 - please keep donating! In the fall, most...

    How do chimpanzees adapt to a savanna woodland in Tanzania?

    75% of Tanzania’s chimpanzees live in open “savanna” woodlands. Considered a marginal habitat due to low food...

    Backer Badge Funded